Abstract | BACKGROUND: METHODS: The human hepatoma cell line HepG2 was used to study the antiapoptotic effect of MK. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/ actinomycin D (ActD)-induced apoptosis was detected using a 2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulphophenyl)-2H-tetrazolium monosodium salt (WST-8) assay, a caspase-3 activity assay, a caspase-8 activity assay, and flow cytometric analysis. RESULTS: TRAIL had a potent, dose-dependent inductive effect on cell death in HepG2 cells, for which viable cell counts decreased to 6.3% of the control count at a TRAIL concentration of 100 ng/mL in the presence of 500 ng/mL ActD. Flow cytometry was used to demonstrate that apoptosis induced by TRAIL/ActD was in fact the cause of cell death. According to the WST-8 assay, MK pretreatment resulted in the suppression of TRAIL/ActD-mediated apoptosis in HepG2 cells, although cell viability did not increase when HepG2 cells were treated with MK alone. Caspase-3 activity was down-regulated when MK was added, but caspase-8 activity was high in both the absence and presence of MK. CONCLUSIONS: The results of the current study indicate that MK acts as an antiapoptotic factor in HepG2 cells through the down-regulation of caspase-3 activity.
|
Authors | Tomoko Ohuchida, Kohji Okamoto, Kazuhisa Akahane, Aiichiro Higure, Hidekazu Todoroki, Yukio Abe, Makoto Kikuchi, Shinya Ikematsu, Takashi Muramatsu, Hideaki Itoh |
Journal | Cancer
(Cancer)
Vol. 100
Issue 11
Pg. 2430-6
(Jun 01 2004)
ISSN: 0008-543X [Print] United States |
PMID | 15160348
(Publication Type: Journal Article)
|
Copyright | Copyright 2004 American Cancer Society. |
Chemical References |
- 2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H tetrazolium monosodium salt
- Apoptosis Regulatory Proteins
- Carrier Proteins
- Cytokines
- Membrane Glycoproteins
- Protein Synthesis Inhibitors
- TNF-Related Apoptosis-Inducing Ligand
- TNFSF10 protein, human
- Tetrazolium Salts
- Tumor Necrosis Factor-alpha
- Midkine
- Dactinomycin
- CASP3 protein, human
- Caspase 3
- Caspases
|
Topics |
- Apoptosis
(drug effects)
- Apoptosis Regulatory Proteins
- Carcinoma, Hepatocellular
(metabolism, pathology)
- Carrier Proteins
(pharmacology)
- Caspase 3
- Caspases
(metabolism)
- Cytokines
(pharmacology)
- Dactinomycin
(pharmacology)
- Down-Regulation
- Flow Cytometry
- Humans
- Liver Neoplasms
(metabolism, pathology)
- Membrane Glycoproteins
(metabolism)
- Midkine
- Protein Synthesis Inhibitors
(pharmacology)
- TNF-Related Apoptosis-Inducing Ligand
- Tetrazolium Salts
(metabolism)
- Tumor Cells, Cultured
(drug effects)
- Tumor Necrosis Factor-alpha
(metabolism)
|